ClinConnect ClinConnect Logo
Search / Trial NCT06882759

Relationship of Point-of-care Coagulation Assays with Clinical Outcomes in Cardiac Surgery: a Retrospective Cohort Study

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Mar 14, 2025

Trial Information

Current as of May 09, 2025

Not yet recruiting

Keywords

Cardiac Surgery Viscoelastic Testing Point Of Care Rotem Cardiopulmonary Bypass Bleeding

ClinConnect Summary

This clinical trial is looking at how a specific test called ROTEM, which measures blood clotting, can help predict bleeding problems in patients who are undergoing heart surgery that requires a heart-lung machine. The researchers want to find out if the results from this test can show which patients might experience excessive bleeding during or after their surgery and how these bleeding issues could affect their recovery.

To be part of this study, participants need to be adults aged 18 or older who have had heart surgery using a heart-lung machine. However, those who did not have the ROTEM test during their surgery will not be included. While the study is not currently recruiting participants, those who take part can expect their ROTEM test results to be analyzed in relation to their surgical outcomes and recovery, helping to improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients ≥ 18 years old
  • Underwent a cardiac surgical procedure with cardiopulmonary bypass
  • Exclusion Criteria:
  • - Did not undergo viscoelastic testing during surgery

About University Health Network, Toronto

University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.

Locations

Patients applied

0 patients applied

Trial Officials

Keyvan Karkouti

Principal Investigator

University Health Network, Toronto

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported